ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO209

Intraglomerular Cross-Talk Between Mesangial Cells and Podocytes Inhibits Normal Endoplasmic Reticulum-Associated Degradation Processes and Induces Podocyte Injury in Diabetes

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • Fujimoto, Daisuke, Kumamoto University, Kumamoto, Japan
  • Kuwabara, Takashige, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • Hata, Yusuke, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • Umemoto, Shuro, Kumamoto University Graduate School of Medicine, Kumamoto, Japan
  • Kanki, Tomoko, Kumamoto University, Kumamoto, Japan
  • Nishiguchi, Yoshihiko, Kumamoto University Hospital, Kumamoto, Japan
  • Mizumoto, Teruhiko, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • Hayata, Manabu, Kumamoto University, Kumamoto, Japan
  • Izumi, Yuichiro, Kumamoto University, Kumamoto, Japan
  • Kakizoe, Yutaka, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • Mukoyama, Masashi, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
Background

Mesangial lesion and podocyte injury are essential for the progression of diabetic kidney disease (DKD). Although cross-communication between mesangial cells (MC) and podocytes is recently suggested by single cell RNA-seq analyses, its molecular mechanisms remain elusive. Our previous experiment on cDNA microarray of diabetic mice glomeruli suggested that ER stress might be involved in DKD progression. The aim of this study is to clarify the effects of MC-podocyte crosstalk on ER stress response of podocytes in diabetic conditions.

Methods

First, we conducted quantitative PCR array focused on ER stress-associated genes. Using cultured mouse podocytes (MPC5) and mouse macrophages (Mφ) stimulated with MC-cultured medium (MC-sup) under high-glucose condition (HG), we evaluated podocyte-specific responses. Further evaluations of ER stress responses of MPC5 were made by Western blotting, real-time PCR and TUNEL staining. The effects of an ER-associated degradation (ERAD) inhibitor Eeyarestatin I (EerI) in MPC5 and db/db mice were also examined.

Results

In vitro, stimulation with HG MC-sup suppressed ERAD-related factors (XBP1, Derlin), and enhanced apoptotic responses in both protein and mRNA levels specifically in MPC5, but not in Mφ. TUNEL staining of MPC5 also showed increased apoptotic cells by HG MC-sup. Those results were augmented by HG MC-sup compared to MC-sup under low-glucose condition. Of note, treatment with EerI recapitulated similar responses, namely suppressed IRE1α, spliced XBP1 and Derlin-2 in MPC5. In vivo, such alterations were also observed in isolated diabetic glomeruli. Administration of EerI significantly exacerbated albuminuria in db/db mice. Expression of genes related to inflammation and fibrosis increased, and immunohistochemistry showed lowered expression of Derlin-2 and nephrin in the glomeruli.

Conclusion

It is recently reported that ERAD pathway may play important roles in the maintenance of podocytes to avoid ER stress in several glomerular diseases including DKD. In this study, we first reveal that intraglomerular crosstalk between MC and podocytes inhibits normal ERAD processes, potentially causing podocyte injury in diabetic conditions.